Bombay Drug House Private Limited · 66-66 · INDIA
For Bombay Drug House Private Limited, import alert is 66-66; country is INDIA; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Albuterol Sulfate; product code is 63 B - S 02 Albuterol Sulfate (Bronchodilator), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Kandivli , Akurli Road , Mumbai, Maharashtra INDIA, verified against its source on 2026-09-30.
- Firm
- Bombay Drug House Private Limited verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- INDIA verified
- Address
- Kandivli , Akurli Road , Mumbai, Maharashtra INDIA verified
- Date published
- 09/30/2009 verified
- Product code
- 63 B - S 02 Albuterol Sulfate (Bronchodilator), Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Albuterol Sulfate verified
- FDA notes
- 10/3/2000 verified
What the source says
Bombay Drug House Private Limited Date Published : 09/30/2009 Kandivli , Akurli Road , Mumbai, Maharashtra INDIA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
63 B - S 02 Albuterol Sulfate (Bronchodilator), Active Pharm Ingred/Chems for Further Manuf Date Published: 10/10/2018 Desc: Albuterol Sulfate Notes: 10/3/2000
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html